Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acasti Pharma Inc (ACST.VN)

Acasti Pharma Inc (ACST.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 25,429
  • Shares Outstanding, K 44,613
  • Annual Sales, $ 0 K
  • Annual Income, $ -42,429 K
  • 60-Month Beta 1.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.19
Trade ACST.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.34
  • Most Recent Earnings $-0.09 on N/A
  • Latest Earnings Date 02/13/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.48
  • Number of Estimates 1
  • High Estimate -0.48
  • Low Estimate -0.48
  • Prior Year -0.42
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.495 +17.17%
on 03/16/23
0.710 -18.31%
on 03/02/23
-0.220 (-27.50%)
since 02/22/23
3-Month
0.495 +17.17%
on 03/16/23
1.120 -48.21%
on 01/23/23
-0.100 (-14.71%)
since 12/23/22
52-Week
0.470 +23.40%
on 12/15/22
1.660 -65.06%
on 04/04/22
-0.980 (-62.82%)
since 03/25/22

Most Recent Stories

More News
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022

Call to be held on Thursday, August 11th at 1:00 PM Eastern Time LAVAL, Quebec, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma Announces Annual Grants of Performance Stock Options

LAVAL, Québec, June 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage,...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma Reports Fiscal Year 2022 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, June 21, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”)...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call

Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints

Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104 Phase 3...

ACST.VN : 0.580 (+1.75%)
ACST : 2.93 (+0.98%)
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

LAVAL, QC / ACCESSWIRE / May 12, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST)(TSXV:ACST), today announced that Jan D'Alvise, Chief Executive Officer, has been invited to present...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th

LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors

LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announces that it...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan

LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), announces the...

ACST : 2.93 (+0.98%)
ACST.VN : 0.580 (+1.75%)
Stocks in play: Acasti Pharma Inc.

Announced that Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma will be presenting ...

ACST.VN : 0.580 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy,...

See More

Key Turning Points

3rd Resistance Point 0.607
2nd Resistance Point 0.593
1st Resistance Point 0.587
Last Price 0.580
1st Support Level 0.567
2nd Support Level 0.553
3rd Support Level 0.547

See More

52-Week High 1.660
Fibonacci 61.8% 1.205
Fibonacci 50% 1.065
Fibonacci 38.2% 0.925
Last Price 0.580
52-Week Low 0.470

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar